Logo image of MNTK

MONTAUK RENEWABLES INC (MNTK) Stock Fundamental Analysis

NASDAQ:MNTK - Nasdaq - US61218C1036 - Common Stock - Currency: USD

4.21  -0.25 (-5.61%)

After market: 4.21 0 (0%)

Fundamental Rating

6

MNTK gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 20 industry peers in the Independent Power and Renewable Electricity Producers industry. Both the profitability and the financial health of MNTK get a neutral evaluation. Nothing too spectacular is happening here. MNTK is growing strongly while it is still valued neutral. This is a good combination! These ratings could make MNTK a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

MNTK had positive earnings in the past year.
In the past year MNTK had a positive cash flow from operations.
MNTK had positive earnings in 4 of the past 5 years.
In the past 5 years MNTK always reported a positive cash flow from operatings.
MNTK Yearly Net Income VS EBIT VS OCF VS FCFMNTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

1.2 Ratios

Looking at the Return On Assets, with a value of 6.14%, MNTK belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
The Return On Equity of MNTK (8.35%) is better than 68.42% of its industry peers.
The Return On Invested Capital of MNTK (8.48%) is better than 89.47% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MNTK is above the industry average of 4.21%.
The last Return On Invested Capital (8.48%) for MNTK is above the 3 year average (7.03%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.14%
ROE 8.35%
ROIC 8.48%
ROA(3y)4.43%
ROA(5y)3.5%
ROE(3y)6.33%
ROE(5y)5.13%
ROIC(3y)7.03%
ROIC(5y)5.5%
MNTK Yearly ROA, ROE, ROICMNTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 5 10 15

1.3 Margins

With a decent Profit Margin value of 11.80%, MNTK is doing good in the industry, outperforming 68.42% of the companies in the same industry.
MNTK's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 17.92%, MNTK is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
In the last couple of years the Operating Margin of MNTK has declined.
With a Gross Margin value of 48.31%, MNTK perfoms like the industry average, outperforming 42.11% of the companies in the same industry.
In the last couple of years the Gross Margin of MNTK has declined.
Industry RankSector Rank
OM 17.92%
PM (TTM) 11.8%
GM 48.31%
OM growth 3Y53.81%
OM growth 5Y-14.87%
PM growth 3Y23.1%
PM growth 5Y-19.15%
GM growth 3Y6.08%
GM growth 5Y-3.85%
MNTK Yearly Profit, Operating, Gross MarginsMNTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 20 30 40 50

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MNTK is destroying value.
The number of shares outstanding for MNTK has been increased compared to 1 year ago.
The number of shares outstanding for MNTK has been increased compared to 5 years ago.
The debt/assets ratio for MNTK has been reduced compared to a year ago.
MNTK Yearly Shares OutstandingMNTK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 50M 100M
MNTK Yearly Total Debt VS Total AssetsMNTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

MNTK has an Altman-Z score of 5.08. This indicates that MNTK is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MNTK (5.08) is better than 94.74% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that MNTK is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.17, MNTK belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 5.08
ROIC/WACC0.97
WACC8.76%
MNTK Yearly LT Debt VS Equity VS FCFMNTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 2.04 indicates that MNTK has no problem at all paying its short term obligations.
MNTK has a Current ratio of 2.04. This is in the better half of the industry: MNTK outperforms 73.68% of its industry peers.
A Quick Ratio of 2.04 indicates that MNTK has no problem at all paying its short term obligations.
MNTK's Quick ratio of 2.04 is fine compared to the rest of the industry. MNTK outperforms 78.95% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 2.04
MNTK Yearly Current Assets VS Current LiabilitesMNTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

MNTK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.00%, which is quite impressive.
The earnings per share for MNTK have been decreasing by -12.06% on average. This is quite bad
MNTK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.63%.
MNTK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.48% yearly.
EPS 1Y (TTM)25%
EPS 3Y51.91%
EPS 5Y-12.06%
EPS Q2Q%33.33%
Revenue 1Y (TTM)9.63%
Revenue growth 3Y20.32%
Revenue growth 5Y8.48%
Sales Q2Q%18.37%

3.2 Future

MNTK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.59% yearly.
Based on estimates for the next years, MNTK will show a quite strong growth in Revenue. The Revenue will grow by 13.98% on average per year.
EPS Next Y83.6%
EPS Next 2Y33.6%
EPS Next 3Y29.92%
EPS Next 5Y20.59%
Revenue Next Year12.44%
Revenue Next 2Y21.64%
Revenue Next 3Y13.98%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MNTK Yearly Revenue VS EstimatesMNTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M 250M
MNTK Yearly EPS VS EstimatesMNTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.1 0.2 0.3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.07 indicates a quite expensive valuation of MNTK.
MNTK's Price/Earnings ratio is a bit cheaper when compared to the industry. MNTK is cheaper than 68.42% of the companies in the same industry.
MNTK is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 23.59, the valuation of MNTK can be described as rather expensive.
Based on the Price/Forward Earnings ratio, MNTK is valued cheaply inside the industry as 84.21% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.68. MNTK is around the same levels.
Industry RankSector Rank
PE 28.07
Fwd PE 23.59
MNTK Price Earnings VS Forward Price EarningsMNTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

MNTK's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MNTK is cheaper than 84.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.15
MNTK Per share dataMNTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of MNTK may justify a higher PE ratio.
A more expensive valuation may be justified as MNTK's earnings are expected to grow with 29.92% in the coming years.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y33.6%
EPS Next 3Y29.92%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MNTK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONTAUK RENEWABLES INC

NASDAQ:MNTK (2/21/2025, 8:00:01 PM)

After market: 4.21 0 (0%)

4.21

-0.25 (-5.61%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)03-13 2025-03-13/amc
Inst Owners19.1%
Inst Owner Change0.17%
Ins Owners53.94%
Ins Owner Change0%
Market Cap603.59M
Analysts48.89
Price Target5.93 (40.86%)
Short Float %3.05%
Short Ratio8.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-45.34%
Min EPS beat(2)-114.52%
Max EPS beat(2)23.84%
EPS beat(4)2
Avg EPS beat(4)-12.76%
Min EPS beat(4)-114.52%
Max EPS beat(4)96.08%
EPS beat(8)2
Avg EPS beat(8)-46.7%
EPS beat(12)2
Avg EPS beat(12)-45.95%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-9.55%
Max Revenue beat(2)5.8%
Revenue beat(4)1
Avg Revenue beat(4)-9.6%
Min Revenue beat(4)-19.3%
Max Revenue beat(4)5.8%
Revenue beat(8)2
Avg Revenue beat(8)-12.39%
Revenue beat(12)4
Avg Revenue beat(12)-5.78%
Revenue beat(16)7
Avg Revenue beat(16)-2.76%
PT rev (1m)-2.11%
PT rev (3m)-7.92%
EPS NQ rev (1m)-17.65%
EPS NQ rev (3m)-48.14%
EPS NY rev (1m)-3.57%
EPS NY rev (3m)-13.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.96%
Valuation
Industry RankSector Rank
PE 28.07
Fwd PE 23.59
P/S 3.1
P/FCF N/A
P/OCF 9.35
P/B 2.19
P/tB 2.35
EV/EBITDA 11.15
EPS(TTM)0.15
EY3.56%
EPS(NY)0.18
Fwd EY4.24%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.45
OCFY10.69%
SpS1.36
BVpS1.92
TBVpS1.79
PEG (NY)0.34
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.14%
ROE 8.35%
ROCE 10.42%
ROIC 8.48%
ROICexc 10.15%
ROICexgc 10.86%
OM 17.92%
PM (TTM) 11.8%
GM 48.31%
FCFM N/A
ROA(3y)4.43%
ROA(5y)3.5%
ROE(3y)6.33%
ROE(5y)5.13%
ROIC(3y)7.03%
ROIC(5y)5.5%
ROICexc(3y)10.13%
ROICexc(5y)7.44%
ROICexgc(3y)10.98%
ROICexgc(5y)8.04%
ROCE(3y)8.63%
ROCE(5y)6.76%
ROICexcg growth 3Y73.93%
ROICexcg growth 5Y-13.72%
ROICexc growth 3Y73.59%
ROICexc growth 5Y-13.71%
OM growth 3Y53.81%
OM growth 5Y-14.87%
PM growth 3Y23.1%
PM growth 5Y-19.15%
GM growth 3Y6.08%
GM growth 5Y-3.85%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 0.81
Cap/Depr 313.21%
Cap/Sales 36.45%
Interest Coverage 6.73
Cash Conversion 112.05%
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 2.04
Altman-Z 5.08
F-Score8
WACC8.76%
ROIC/WACC0.97
Cap/Depr(3y)149.84%
Cap/Depr(5y)152.02%
Cap/Sales(3y)17.88%
Cap/Sales(5y)22.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25%
EPS 3Y51.91%
EPS 5Y-12.06%
EPS Q2Q%33.33%
EPS Next Y83.6%
EPS Next 2Y33.6%
EPS Next 3Y29.92%
EPS Next 5Y20.59%
Revenue 1Y (TTM)9.63%
Revenue growth 3Y20.32%
Revenue growth 5Y8.48%
Sales Q2Q%18.37%
Revenue Next Year12.44%
Revenue Next 2Y21.64%
Revenue Next 3Y13.98%
Revenue Next 5YN/A
EBIT growth 1Y23.58%
EBIT growth 3Y85.07%
EBIT growth 5Y-7.65%
EBIT Next Year103.55%
EBIT Next 3Y37.6%
EBIT Next 5Y20.34%
FCF growth 1Y-109.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.71%
OCF growth 3Y12.7%
OCF growth 5Y-3.74%